Curated Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Curated Wealth Partners’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Buy	+36,738	New	+$25M	0.13%	137

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Curated Wealth Partners's REGN Position: Q2 2026 in Review

Curated Wealth Partners opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 36,738 shares worth $1.01M. The stake represents 0.13% of the portfolio and ranks #137 among its holdings.

397 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Curated Wealth Partners held 36,738 shares of Regeneron Pharmaceuticals worth $1.01M as of Q2 2026.
Regeneron Pharmaceuticals was a new Curated Wealth Partners position in Q2 2026.
Regeneron Pharmaceuticals made up 0.13% of Curated Wealth Partners's portfolio in Q2 2026, its #137 holding.
397 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.